Metaplastic Breast Cancer Has a Poor Response to Neoadjuvant Systemic Therapy

被引：0
|
作者：
Al-Hilli, Zahraa [1 ]
Jakub, James [1 ]
Visscher, Daniel [1 ]
Ingle, James [1 ]
Goetz, Matthew [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0313
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [1] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
    Zahraa Al-Hilli
    Grace Choong
    Michael G. Keeney
    Daniel W. Visscher
    James N. Ingle
    Matthew P. Goetz
    James W. Jakub
    [J]. Breast Cancer Research and Treatment, 2019, 176 : 709 - 716
  • [2] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
    Al-Hilli, Zahraa
    Choong, Grace
    Keeney, Michael G.
    Visscher, Daniel W.
    Ingle, James N.
    Goetz, Matthew P.
    Jakub, James W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (03) : 709 - 716
  • [3] Metaplastic breast cancer: Prognosis and response to systemic therapy
    Rayson, D
    Adjei, AA
    Suman, VJ
    Wold, LE
    Ingle, JN
    [J]. ANNALS OF ONCOLOGY, 1999, 10 (04) : 413 - 419
  • [4] Poor Response to Neoadjuvant Chemotherapy in Metaplastic Breast Carcinoma
    Wong, Willard
    Brogi, Edi
    Plitas, George
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 284 - 285
  • [5] Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
    Wong, Willard
    Brogi, Edi
    Reis-Filho, Jorge S.
    Plitas, George
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah Y.
    [J]. NPJ BREAST CANCER, 2021, 7 (01)
  • [6] Poor Response to Neoadjuvant Chemotherapy in Metaplastic Breast Carcinoma
    Wong, Willard
    Brogi, Edi
    Plitas, George
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 284 - 285
  • [7] Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
    Willard Wong
    Edi Brogi
    Jorge S. Reis-Filho
    George Plitas
    Mark Robson
    Larry Norton
    Monica Morrow
    Hannah Y. Wen
    [J]. npj Breast Cancer, 7
  • [8] Poor response to systemic chemotherapy in metaplastic carcinoma of breast
    Chen, I. C.
    Lu, Y. S.
    Lin, C. H.
    Huang, C. S.
    Cheng, A. L.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 289 - 289
  • [9] Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)
    Yam, C.
    Seth, S.
    Hess, K. R.
    Mittendorf, E. A.
    Murthy, R. K.
    Damodaran, S.
    Helgason, T.
    Huo, L.
    Thompson, A. M.
    Barton, M.
    Huang, M. L.
    Arribas, E. M.
    Lane, D. L.
    Rauch, G. M.
    Adrada, B. E.
    Gilcrease, M. Z.
    Chang, J. T.
    Moulder, S. L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [10] Metaplastic carcinoma of the breast has comparable prognosis to non-metaplastic triple negative breast cancer despite poor response to chemotherapy
    Lim, Changjin
    Kim, Jang-il
    Han, Yireh
    Cheun, Jong-ho
    Jung, Ji Gwang
    Kim, Hong Kyu
    Moon, Hyeong-Gon
    Han, Wonshik
    Lee, Han-Byoel
    [J]. CANCER RESEARCH, 2022, 82 (04)
12345